Retrospective Evaluation on the Use of a New Polysaccharide Complex in Managing Paediatric Type 1 Diabetes with Metabolic Syndrome (MetS).
Stefano StagiValeria PapacciuoliDaniele CiofiBarbara PicciniGiovanni FarelloSonia ToniMarta FerrariFrancesco ChiarelliPublished in: Nutrients (2021)
PGR produces a good auxological and metabolic response in obese patients with MetS who are affected by type 1 diabetes. It led to a significant reduction in BMI SDS, waist SDS and an improvement in glucose control and variability as well as in other MetS parameters. The use of polysaccharide compounds, especially if associated with appropriate dietary changes, may help achieve treatment targets in type 1 diabetes and reduce the risk that patients develop metabolic syndrome.
Keyphrases
- type diabetes
- metabolic syndrome
- insulin resistance
- glycemic control
- body mass index
- end stage renal disease
- cardiovascular disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- emergency department
- uric acid
- adipose tissue
- intensive care unit
- cross sectional
- prognostic factors
- weight loss
- blood pressure
- weight gain